Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000929638-25-002528
Filing Date
2025-07-08
Accepted
2025-07-08 16:08:46
Documents
2
Period of Report
2025-07-08

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 4252
2 POWER OF ATTORNEY exhbit24.htm EX-24 4576
  Complete submission text file 0000929638-25-002528.txt   10266
Mailing Address C/O ZIOPHARM ONCOLOGY, INC. ONE FIRST AVENUE, PARRIS BUILDING 34 BOSTON MA 02129
Business Address
Buck Jill (Reporting) CIK: 0001780426 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41854 | Film No.: 251111142

Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1
Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888
enGene Holdings Inc. (Issuer) CIK: 0001980845 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)